However, if youre not seeing the needle move by that point or have concerns, experts say you have options
Similarly, Cui et al
GLP-1s were associated with lower risk of new substance use disorder diagnoses Across alcohol, cannabis, cocaine, nicotine, opioids, and other drug categories, people who started a GLP-1 medication were less likely to receive a new substance use disorder diagnosis over the following 3 years relative to those who started the comparison diabetes medication, sodium-glucose cotransporter-2 inhibitor
Take Our AI Quiz : If you're unsure which supplements fit your needs, our tool can help identify solutions aligned with your goals
The present investigation has been supported partly by funds from the American Diabetes Association and the National Institutes of Health (1-17-IBS-258 and R21DK113446-01 to MDiF)
According to a review of 143 studies, GLP-1 receptor agonists, including Semaglutide, showed high effectiveness in reducing total body weight [1]